Eli Lilly reports strong Q3 2025 earnings and revenue exceeding expectations

seekingalpha.com

Eli Lilly reported strong Q3 2025 results, with earnings per share exceeding expectations. The company announced revenue of $17.60 billion, a significant year-over-year increase, also surpassing analyst predictions. These results were shared during their Q3 2025 earnings call on October 30, 2025.


With a significance score of 1.1, this news ranks in the top 53% of today's 32263 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: